X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (216) 216
hematology (153) 153
female (133) 133
male (120) 120
index medicus (118) 118
adult (101) 101
oncology (99) 99
middle aged (94) 94
animals (68) 68
transplantation (57) 57
mice (54) 54
leukemia (53) 53
medicine & public health (53) 53
stem cells (45) 45
cord blood transplantation (42) 42
adolescent (39) 39
aged (38) 38
bone-marrow-transplantation (34) 34
cancer (34) 34
stem-cell transplantation (33) 33
analysis (31) 31
transplantation, homologous (31) 31
hematopoietic stem cells (29) 29
treatment outcome (29) 29
expression (26) 26
biochemistry & molecular biology (23) 23
bone marrow (23) 23
stem-cells (23) 23
cell biology (22) 22
immunology (22) 22
retrospective studies (22) 22
bone-marrow (21) 21
base sequence (20) 20
young adult (20) 20
cell line (19) 19
cord blood stem cell transplantation (19) 19
molecular sequence data (19) 19
bone marrow transplantation (18) 18
medical colleges (18) 18
adult patients (17) 17
cell line, tumor (17) 17
chemotherapy (17) 17
cord blood stem cell transplantation - adverse effects (17) 17
cord blood stem cell transplantation - methods (17) 17
hematologic neoplasms - therapy (17) 17
recipients (17) 17
transplantation conditioning - methods (17) 17
chronic myelogenous leukemia (16) 16
flow cytometry (16) 16
medical research (16) 16
survival (16) 16
unrelated donors (16) 16
acute myeloid-leukemia (15) 15
differentiation (15) 15
hematology, oncology and palliative medicine (15) 15
time factors (15) 15
biophysics (14) 14
cells, cultured (14) 14
disease (14) 14
disease progression (14) 14
disease-free survival (14) 14
donors (14) 14
hematologic malignancies (14) 14
leukemia, myeloid, acute - therapy (14) 14
lymphoma (14) 14
medicine, experimental (14) 14
t cells (14) 14
therapy (14) 14
adults (13) 13
blood (13) 13
health aspects (13) 13
hemic and lymphatic diseases (13) 13
kinetics (13) 13
medicine, research & experimental (13) 13
patients (13) 13
recurrence (13) 13
relapse (13) 13
biotechnology & applied microbiology (12) 12
cell differentiation (12) 12
genetic aspects (12) 12
infection (12) 12
mesenchymal stromal cells - cytology (12) 12
myelodysplastic syndrome (12) 12
myeloid leukemia (12) 12
polymerase chain reaction (12) 12
research (12) 12
risk factors (12) 12
transplantation conditioning (12) 12
versus-host-disease (12) 12
whole-body irradiation (12) 12
acute disease (11) 11
acute myelogenous leukemia (11) 11
cell & tissue engineering (11) 11
cell division - drug effects (11) 11
cell proliferation (11) 11
chronic myeloid leukemia (11) 11
chronic myeloid-leukemia (11) 11
colony-stimulating factor (11) 11
hematopoietic stem cell transplantation (11) 11
leukemia, myelogenous, chronic, bcr-abl positive - therapy (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


[Rinsho ketsueki] The Japanese journal of clinical hematology, ISSN 0485-1439, 2017, Volume 58, Issue 10, p. 1913
Next generation sequencing (NGS) of cancer genomes is now becoming a prerequisite for accurate diagnosis and proper treatment in clinical oncology. Because the... 
Artificial Intelligence | Humans | High-Throughput Nucleotide Sequencing | Leukemia - genetics
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 05/2018, Volume 45, Issue 5, pp. 801 - 805
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2018, Volume 41, Issue 2, pp. 254 - 258
Ponatinib, a novel tyrosine kinase inhibitor marketed in 2016, is a key drug used for treating chronic myeloid leukemia and Philadelphia chromosome-positive... 
human plasma concentration | HPLC equipped with UV detection method | ponatinib | bosutinib | Human plasma concentration | Ponatinib | Bosutinib | TYROSINE KINASE INHIBITORS | TRIAL | PHARMACOKINETICS | EFFICACY | IMATINIB | CHROMOSOME-POSITIVE LEUKEMIAS | PHARMACOLOGY & PHARMACY | CANCER | Humans | Imidazoles - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Antineoplastic Agents - therapeutic use | Chromatography, High Pressure Liquid | Imidazoles - pharmacokinetics | Cost Savings | Protein Kinase Inhibitors - chemistry | Adult | Antineoplastic Agents - pharmacokinetics | Imidazoles - therapeutic use | Pyridazines - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Limit of Detection | Reproducibility of Results | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood | Drug Stability | Calibration | Antineoplastic Agents - chemistry | Spectrophotometry, Ultraviolet | Protein Kinase Inhibitors - blood | Pyridazines - chemistry | Imidazoles - blood | Pyridazines - blood | Protein Kinase Inhibitors - therapeutic use | Antineoplastic Agents - blood | Pyridazines - pharmacokinetics | Analytic Sample Preparation Methods | Regression coefficients | Tyrosine | Plasma | Acute lymphatic leukemia | Myeloid leukemia | Leukemia | Flow rates | Liquid chromatography | Chronic myeloid leukemia | Economic conditions | Regression analysis | Lymphatic leukemia | Kinases | High-performance liquid chromatography | Philadelphia chromosome | Potassium phosphate | Ultraviolet radiation | Acetonitrile | Potassium phosphates | Flow velocity | Chromosomes | Protein-tyrosine kinase
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 06/2014, Volume 72, Issue 6, pp. 1118 - 1124
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 06/2014, Volume 72, Issue 6, p. 1118
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2018, Volume 41, Issue 2, pp. 254 - 258
Ponatinib, a novel tyrosine kinase inhibitor marketed in 2016, is a key drug used for treating chronic myeloid leukemia and Philadelphia chromosome-positive... 
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 7/2019, Volume 25, Issue 8, pp. 1141 - 1149
Objective: To investigate characteristics of multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients associated with drugs other than... 
demography | fingolimod | multiple sclerosis | time to onset | natalizumab | rituximab | Progressive multifocal leukoencephalopathy | CELLS | NEUROSCIENCES | CLINICAL NEUROLOGY | Rituximab | Multiple sclerosis | Leukoencephalopathy
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5793 - 5793
Abstract Oncolytic viruses have a great potential to provide clinical improvement for cancer patients who do not respond to conventional therapies. The... 
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. LB-356 - LB-356
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2015, Volume 26, Issue suppl 7, pp. vii31.2 - vii31
Journal Article
International Journal of Hematology, ISSN 0925-5710, 10/2011, Volume 94, Issue 4, pp. 413 - 414
Byline: Yasuo Oshima (1), Arinobu Tojo (1) Author Affiliation: (1) The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku,... 
Nilotinib | Spontaneous Report | Dasatinib | Adverse Drug Reaction | Sunitinib | Medicine & Public Health | Hematology | Oncology | HEMATOLOGY | Product Surveillance, Postmarketing - statistics & numerical data | Drug-Related Side Effects and Adverse Reactions | Hyperthyroidism | Japan | Databases, Factual
Journal Article
International Journal of Hematology, ISSN 0925-5710, 10/2018, Volume 108, Issue 4, pp. 402 - 410
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.